Showing results (411-420 of 420) with videos related to
Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
Bone Marrow Transplantation|May 22, 2024
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trialsC Ganzel, Y Wang, K Roopcharan, et al.Leukemia Research|October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remissionR P Gale, R E Park, R W Dubois, et al.Leukemia Research|September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phaseR P Gale, R E Park, R W Dubois, et al.Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.Bone Marrow Transplantation|December 18, 2007
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ResearchM R Bishop, B R Logan, S Gandham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's diseaseJ L Gajewski, G L Phillips, K A Sobocinski, et al.Bone Marrow Transplantation|October 6, 2015
Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphomaE Klyuchnikov, U Bacher, K Woo Ahn, et al.Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients /=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.Pageof 42